Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Algorithm-based Management to Reduce the Recurrence of Gastrointestinal Bleeding and Severe Epistaxis in Von Willebrand Disease: WILL-MANAGE Trial

NCT06651255 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT06651255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06651255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Algorithm-based Management to Reduce the Recurrence of Gastrointestinal Bleeding and Severe Epistaxis in Von Willebrand Disease: WILL-MANAGE Trial
Lead sponsor
University Hospital, Lille
Phase
Not applicable
Overall status
Recruiting
Start date
March 10, 2026
Completion date
March 31, 2032
Enrollment
66 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

von willebrand disease (vwd)